Skip Header

Contribute Send feedback
Read comments (0) or add your own

Reviewed, UniProtKB/Swiss-Prot Q9BY76 (ANGL4_HUMAN)

Last modified January 19, 2010. Version 82. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (5) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    Angiopoietin-related protein 4
Alternative name(s):
    Angiopoietin-like protein 4
    Hepatic fibrinogen/angiopoietin-related protein
      Short name=HFARP
Gene names
Name: ANGPTL4
Synonyms: ARP4, HFARP, PGAR
ORF Names: PP1158, PSEC0166, UNQ171/PRO197
OrganismHomo sapiens (Human) [Complete proteome]
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length406 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is further processed into a mature form.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

Protein with hypoxia-induced expression in endothelial cells. May act as a regulator of angiogenesis and modulate tumorgenesis. Inhibits proliferation, migration, and tubule formation of endothelial cells and reduces vascular leakage. May exert a protective function on endothelial cells through an endocrine action. It is directly involved in regulating glucose homeostasis, lipid metabolism, and insulin sensitivity. In response to hypoxia, the unprocessed form of the protein accumulates in the subendothelial extracellular matrix (ECM). The matrix-associated and immobilized unprocessed form limits the formation of actin stress fibers and focal contacts in the adhering endothelial cells and inhibits their adhesion. It also decreases motility of endothelial cells and inhibits the sprouting and tube formation By similarity. Ref.2 Ref.4 Ref.9

Subunit structure

Homooligomer. The homooligomer undergoes proteolytic processing to release its carboxyl fibrinogen-like domain, which circulates as a monomer. The homooligomer unprocessed form is able to interact with the extracellular matrix By similarity.

Subcellular location

Secreted. Secretedextracellular spaceextracellular matrix By similarity. Note: The unprocessed form interacts with the extracellular matrix. This may constitute a dynamic reservoir, a regulatory mechanism of the bioavailability of ANGPTL4 By similarity. Ref.1

Tissue specificity

Expressed at high levels in the placenta, heart, liver, muscle, pancreas and lung but expressed poorly in the brain and kidney. Ref.9 Ref.1

Post-translational modification

N-glycosylated. Ref.1

Sequence similarities

Contains 1 fibrinogen C-terminal domain.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Signal peptide1 – 2525 Potential
Chain26 – 406381Angiopoietin-related protein 4
PRO_0000009124

Regions

Domain179 – 401223Fibrinogen C-terminal
Coiled coil100 – 14344 Potential

Amino acid modifications

Glycosylation1771N-linked (GlcNAc...) Potential
Disulfide bond188 ↔ 216 By similarity
Disulfide bond341 ↔ 354 By similarity

Natural variations

Natural variant51P → L
VAR_032642
Natural variant401E → K Associated with lower plasma levels of triglyceride and higher levels of HDL cholesterol. Ref.10
VAR_032643
Natural variant411M → I
VAR_032644
Natural variant671S → R
VAR_032645
Natural variant721R → L
VAR_032646
Natural variant771G → R
VAR_032647
Natural variant1671E → K
VAR_032648
Natural variant1741P → S
VAR_032649
Natural variant1901E → Q
VAR_032650
Natural variant1961E → K
VAR_032651
Natural variant2301R → C
VAR_032652
Natural variant2331G → R
VAR_032653
Natural variant2371F → V
VAR_032654
Natural variant2511P → T
VAR_032655
Natural variant2661T → M: dbSNP rs1044250. Ref.1 Ref.10 Ref.7
VAR_020428
Natural variant2781R → Q: dbSNP rs35061979. Ref.10
VAR_032656
Natural variant2911V → M
VAR_032657
Natural variant2931L → M
VAR_032658
Natural variant2961E → V
VAR_032659
Natural variant3071P → S
VAR_032660
Natural variant3081V → M
VAR_032661
Natural variant3361R → C
VAR_032662
Natural variant3381D → E
VAR_032663
Natural variant3491W → C
VAR_032664
Natural variant3611G → R
VAR_032665
Natural variant3611G → S
VAR_032666
Natural variant3711R → Q
VAR_032667
Natural variant3841R → W
VAR_032668

Experimental info

Sequence conflict55 – 7117LREHA…SALER → CANTGAHPQSAERAGA in AAD41088. Ref.5
Sequence conflict601E → G in BAB40692. Ref.4
Sequence conflict1751A → P in AAF62868. Ref.1
Sequence conflict2511P → S in BAD96209. Ref.7
Sequence conflict2701N → D in BAD96209. Ref.7
Sequence conflict2771L → R in BAD96244. Ref.7
Sequence conflict3041L → F in AAF62868. Ref.1
Sequence conflict3631Y → H in BAD96209. Ref.7
Sequence conflict3891P → S in AAF62868. Ref.1

Sequences

Sequence LengthMass (Da)Tools
Q9BY76-1 [UniParc].

Last modified November 8, 2002. Version 2.
Checksum: 219E56FEB3F602AF

FASTA40645,214
        10         20         30         40         50         60 
MSGAPTAGAA LMLCAATAVL LSAQGGPVQS KSPRFASWDE MNVLAHGLLQ LGQGLREHAE 

        70         80         90        100        110        120 
RTRSQLSALE RRLSACGSAC QGTEGSTDLP LAPESRVDPE VLHSLQTQLK AQNSRIQQLF 

       130        140        150        160        170        180 
HKVAQQQRHL EKQHLRIQHL QSQFGLLDHK HLDHEVAKPA RRKRLPEMAQ PVDPAHNVSR 

       190        200        210        220        230        240 
LHRLPRDCQE LFQVGERQSG LFEIQPQGSP PFLVNCKMTS DGGWTVIQRR HDGSVDFNRP 

       250        260        270        280        290        300 
WEAYKAGFGD PHGEFWLGLE KVHSITGDRN SRLAVQLRDW DGNAELLQFS VHLGGEDTAY 

       310        320        330        340        350        360 
SLQLTAPVAG QLGATTVPPS GLSVPFSTWD QDHDLRRDKN CAKSLSGGWW FGTCSHSNLN 

       370        380        390        400 
GQYFRSIPQQ RQKLKKGIFW KTWRGRYYPL QATTMLIQPM AAEAAS 

« Hide

References

« Hide 'large scale' references
[1]"Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis."
Kim I., Kim H.-G., Kim H., Kim H.-H., Park S.K., Uhm C.-S., Lee Z.H., Koh G.Y.
Biochem. J. 346:603-610(2000) [PubMed: 10698685] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, SUBCELLULAR LOCATION, GLYCOSYLATION, VARIANT MET-266.
[2]"Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation."
Yoon J.C., Chickering T.W., Rosen E.D., Dussault B., Qin Y., Soukas A., Friedman J.M., Holmes W.E., Spiegelman B.M.
Mol. Cell. Biol. 20:5343-5349(2000) [PubMed: 10866690] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA], POSSIBLE FUNCTION.
Tissue: Aortic endothelium.
[3]"Cloning of a novel gene, ANGPTL4 and the functional study in angiogenesis."
Zhu H., Li J., Qin W., Yang Y., He X., Wan D., Gu J.
Zhonghua Yi Xue Za Zhi 82:94-99(2002) [PubMed: 11953136] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA].
Tissue: Placenta.
[4]"Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4."
Ito Y., Oike Y., Yasunaga K., Hamada K., Miyata K., Matsumoto S., Sugano S., Tanihara H., Masuho Y., Suda T.
Cancer Res. 63:6651-6657(2003) [PubMed: 14583458] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION.
Tissue: Placenta.
[5]"A catalogue of genes in the human dermal papilla cells as identified by expressed sequence tags."
Kim M.K., Kim Y.H., Seo J.M., Lee H.M., Chung H.J., Sohn M.Y., Hwang S.Y., Im S.U., Jung E.J., Lee J.H., Kim J.C.
Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Tissue: Hair follicle dermal papilla.
[6]"The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment."
Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J., Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P., Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E. expand/collapse author list , Heldens S., Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.
Genome Res. 13:2265-2270(2003) [PubMed: 12975309] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
[7]Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.
Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANT MET-266.
Tissue: Adipose tissue.
[8]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Tissue: Pancreas.
[9]"Expression and function of hepatocellular carcinoma-related gene pp1158."
Zhu H., Li J., Wan D., Yang Y., Qin W., Ge C., Yao M., Gu J.
Zhonghua Zhong Liu Za Zhi 24:123-125(2002) [PubMed: 12015030] [Abstract]
Cited for: FUNCTION, TISSUE SPECIFICITY.
[10]"Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL."
Romeo S., Pennacchio L.A., Fu Y., Boerwinkle E., Tybjaerg-Hansen A., Hobbs H.H., Cohen J.C.
Nat. Genet. 39:513-516(2007) [PubMed: 17322881] [Abstract]
Cited for: VARIANTS LEU-5; LYS-40; ILE-41; ARG-67; LEU-72; ARG-77; LYS-167; SER-174; GLN-190; LYS-196; CYS-230; ARG-233; VAL-237; THR-251; MET-266; GLN-278; MET-291; MET-293; VAL-296; SER-307; MET-308; CYS-336; GLU-338; CYS-349; SER-361; ARG-361; GLN-371 AND TRP-384.
+Additional computationally mapped references.

Cross-references

Sequence databases

EMBL
GenBank
DDBJ
AF169312 mRNA. Translation: AAF62868.1.
AF202636 mRNA. Translation: AAG22490.1.
AB056477 mRNA. Translation: BAB40692.1.
AF153606 mRNA. Translation: AAD41088.1.
AY358275 mRNA. Translation: AAQ88642.1. Different initiation.
AK222489 mRNA. Translation: BAD96209.1.
AK222524 mRNA. Translation: BAD96244.1.
BC023647 mRNA. Translation: AAH23647.1.
IPIIPI00153060.
RefSeqNP_001034756.1.
NP_647475.1.
UniGeneHs.9613

3D structure databases

SMRQ9BY76. Positions 186-400.
ModBaseSearch...

Protein-protein interaction databases

STRINGQ9BY76.

Proteomic databases

PRIDEQ9BY76.

Genome annotation databases

EnsemblENST00000301455; ENSP00000301455; ENSG00000167772; Homo sapiens. [Genome view]
GeneID51129.
KEGGhsa:51129.
UCSCuc002mjq.1. human.

Organism-specific databases

CTD51129.
GeneCardsGC19P008335.
H-InvDBHIX0027444.
HGNCHGNC:16039. ANGPTL4.
HPAHPA007879.
MIM605910. gene.
PharmGKBPA24797.
GenAtlasSearch...

Phylogenomic databases

eggNOGprNOG09521.
HOVERGENQ9BY76.
InParanoidQ9BY76.
OMAMRCAPTA.
OrthoDBEOG9QJV6X.
PhylomeDBQ9BY76.

Enzyme and pathway databases

ReactomeREACT_602. Metabolism of lipids and lipoproteins.

Gene expression databases

ArrayExpressQ9BY76.
BgeeQ9BY76.
CleanExHS_ANGPTL4.
GenevestigatorQ9BY76.
GermOnlineENSG00000167772. Homo sapiens.

Family and domain databases

InterProIPR002181. Fibrinogen_a/b/g_C.
IPR014716. Fibrinogen_a/b/g_C_1.
IPR014715. Fibrinogen_a/b/g_C_2.
IPR020837. Fibrinogen_CS.
[Graphical view]
Gene3DG3DSA:3.90.215.10. Fibrinogen_a/b/g_C_1. 1 hit.
G3DSA:4.10.530.10. Fibrinogen_a/b/g_C_2. 1 hit.
PfamPF00147. Fibrinogen_C. 1 hit.
[Graphical view]
SMARTSM00186. FBG. 1 hit.
[Graphical view]
PROSITEPS00514. FIBRINOGEN_C_1. 1 hit.
PS51406. FIBRINOGEN_C_2. 1 hit.
[Graphical view]
ProtoNetSearch...

Other Resources

NextBio53949.
SOURCESearch...

Entry information

Entry nameANGL4_HUMAN
AccessionPrimary (citable) accession number: Q9BY76
Secondary accession number(s): Q53HQ6 expand/collapse secondary AC list , Q53HU1, Q6UXN0, Q9HBV4, Q9NZU4, Q9Y5B3
Entry history
Integrated into UniProtKB/Swiss-Prot: November 8, 2002
Last sequence update: November 8, 2002
Last modified: January 19, 2010
This is version 82 of the entry and version 2 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation projectHPI (Human Proteome Initiative)
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Relevant documents

Human chromosome 19

Human chromosome 19: entries, gene names and cross-references to MIM

Human entries with polymorphisms or disease mutations

List of human entries with polymorphisms or disease mutations

Human polymorphisms and disease mutations

Index of human polymorphisms and disease mutations

MIM cross-references

Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot

SIMILARITY comments

Index of protein domains and families

Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents